Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 300

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Open access
Daher, May, Basar, Rafet, Gokdemir, Elif, Baran, Natalia, Uprety, Nadima, Nunez Cortes, Ana Karen, Mendt, Mayela, Kerbauy, Lucila Nassif, Banerjee, Pinaki P., Shanley, Mayra, Imahashi, Nobuhiko, Li, Li, Lim, Francesca Lorraine Wei Inng, Fathi, Mohsen, Rezvan, Ali, Mohanty, Vakul, Shen, Yifei, Shaim, Hila, Lu, Junjun, Ozcan, Gonca, Ensley, Emily, Kaplan, Mecit, Nandivada, Vandana, Bdiwi, Mustafa, Acharya, Sunil, Xi, Yuanxin, Wan, Xinhai, Mak, Duncan, Liu, Enli, Jiang, Xin Ru, Ang, Sonny, Muniz-Feliciano, Luis, Li, Ye, Wang, Jing, Kordasti, Shahram, Petrov, Nedyalko, Varadarajan, Navin, Marin, David, Brunetti, Lorenzo, Skinner, Richard J., Lyu, Shangrong, Silva, Leiser, Turk, Rolf, Schubert, Mollie S., Rettig, Garrett R., McNeill, Matthew S., Kurgan, Gavin, Behlke, Mark A., Li, Heng, Fowlkes, Natalie W., Chen, Ken, Konopleva, Marina, Champlin, Richard E., Shpall, Elizabeth J., Rezvani, Katayoun · 2021 · Blood

Abstract

Immune checkpoint therapy has resulted in remarkable improvements in the outcome for certain cancers. To broaden the clinical impact of checkpoint targeting, we devised a strategy that couples targeting of the cytokine-inducible Src homology 2–containing (CIS) protein, a key negative regulator of interleukin 15 (IL-15) signaling, with fourth-generation “armored” chimeric antigen receptor (CAR) engineering of cord blood–derived natural killer (NK) cells. This combined strategy boosted NK cell effector function through enhancing the Akt/mTORC1 axis and c-MYC signaling, resulting in increased aerobic glycolysis. When tested in a lymphoma mouse model, this combined approach improved NK cell antitumor activity more than either alteration alone, eradicating lymphoma xenografts without signs of any measurable toxicity. We conclude that targeting a cytokine checkpoint further enhances the antitumor activity of IL-15–secreting armored CAR-NK cells by promoting their metabolic fitness and antitumor activity. This combined approach represents a promising milestone in the development of the next generation of NK cells for cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2020007748

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 300

Metadata

Authors
Daher, M., Basar, R., Gokdemir, E., Baran, N., Uprety, N., Nunez Cortes, A. K., Mendt, M., Kerbauy, L. N., Banerjee, P. P., Shanley, M., Imahashi, N., Li, L., Lim, F. L. W. I., Fathi, M., Rezvan, A., Mohanty, V., Shen, Y., Shaim, H., Lu, J., Ozcan, G., Ensley, E., Kaplan, M., Nandivada, V., Bdiwi, M., Acharya, S., Xi, Y., Wan, X., Mak, D., Liu, E., Jiang, X. R., Ang, S., Muniz-Feliciano, L., Li, Y., Wang, J., Kordasti, S., Petrov, N., Varadarajan, N., Marin, D., Brunetti, L., Skinner, R. J., Lyu, S., Silva, L., Turk, R., Schubert, M. S., Rettig, G. R., McNeill, M. S., Kurgan, G., Behlke, M. A., Li, H., Fowlkes, N. W., Chen, K., Konopleva, M., Champlin, R. E., Shpall, E. J., & Rezvani, K.
Venue
Blood
Published
2021-02-04
Volume
137
Issue
5
Pages
624-636
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3084409374
Cited by
300
References
42
FWCI
11.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. https://app.cochat.ai/papers/10.1182/blood.2020007748
The paper
Daher, M., Basar, R., Gokdemir, E., Baran, N., Uprety, N., Nunez Cortes, A. K., Mendt, M., Kerbauy, L. N., Banerjee, P. P., Shanley, M., Imahashi, N., Li, L., Lim, F. L. W. I., Fathi, M., Rezvan, A., Mohanty, V., Shen, Y., Shaim, H., Lu, J., . . . Rezvani, K. (2021). Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood. https://doi.org/10.1182/blood.2020007748

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.